US Stock MarketDetailed Quotes

KPTI Karyopharm Therapeutics

Watchlist
  • 0.845
  • +0.067+8.67%
Close Nov 22 16:00 ET
  • 0.835
  • -0.010-1.17%
Post 19:24 ET
105.89MMarket Cap-804P/E (TTM)

Karyopharm Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Karyopharm Therapeutics Q3 2024 Earnings Date

Currency：USDNov 5, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
37.92M
38.78M
+859.00K
Beat Est.
+5.32%
+7.70%
+2.27%
EPS
-0.29
-0.26
+0.03
Beat Est.
+1.67%
+13.33%
+11.83%
Analyst Rating
Strong Buy

Nov 8, 2024

Karyopharm Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 45.712M--
--2024/Q4-- / 38.195M--
Nov 5, 20242024/Q338.783M / 37.924M--
Aug 6, 20242024/Q242.786M / 36.213M--
May 8, 20242024/Q133.126M / 34.473M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 45.712M--
--2024/Q4-- / 38.195M--
Nov 5, 20242024/Q338.783M / 37.924M--
Aug 6, 20242024/Q242.786M / 36.213M--
May 8, 20242024/Q133.126M / 34.473M--

Unlock Free Earnings Estimates

Karyopharm Therapeutics Earnings Reports

  • Karyopharm Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 5 07:51 ET

  • Karyopharm Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 6 07:43 ET

  • Karyopharm Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 8 17:18 ET

  • Karyopharm Therapeutics | 10-K: FY2023 Annual Report

    Feb 29 07:48 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 8, 2024

    Strong Buy

    • Buy

      83.33%

    • Hold

      16.67%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data